Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorena Rami

Showing results (31-40 of 115) with videos related to

Pageof 12
Sort By:
Journal of Alzheimer'S Disease : JAD|January 30, 2018
Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-β and TauAlan Tucholka, Oriol Grau-Rivera, Carles Falcon, et al.
Dementia and Geriatric Cognitive Disorders Extra|September 26, 2014
Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's DiseaseChristoffer Rosén, Carl-Henrik Andersson, Ulf Andreasson, et al.
Journal of Alzheimer'S Disease : JAD|March 1, 2014
Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impairmentMircea Balasa, Raquel Sánchez-Valle, Anna Antonell, et al.
Journal of Alzheimer'S Disease : JAD|September 18, 2010
Greater default-mode network abnormalities compared to high order visual processing systems in amnestic mild cognitive impairment: an integrated multi-modal MRI studyRoser Sala-Llonch, Beatriz Bosch, Eider M Arenaza-Urquijo, et al.
Journal of Alzheimer'S Disease : JAD|October 8, 2015
Informants' Perception of Subjective Cognitive Decline Helps to Discriminate Preclinical Alzheimer's Disease from Normal AgingNatalia Valech, María A Mollica, Jaume Olives, et al.
The Journal of ECT|April 26, 2012
Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot studyLuis Pérez Pintor, Francesc Valldeoriola, Emilio Fernández-Egea, et al.
Frontiers in Psychiatry|February 23, 2026
Evaluating contributions of neuropsychological, psychiatric, and inflammatory processes to the expression of cognitive symptoms in post-acute COVID-19 syndromeLuke S Watson, Youssef Toubouti, Sarah M Gray, et al.
Revista De Neurologia|April 26, 2012
[A new approach to the Alzheimer's disease diagnosis with biomarkers: description of the AD-CSF-Index]José L Molinuevo, Juan D Gispert, Jesús Pujol, et al.
Psychiatry Research|May 7, 2011
Association between cerebrospinal fluid tau and brain atrophy is not related to clinical severity in the Alzheimer's disease continuumCristina Solé-Padullés, Albert Lladó, David Bartrés-Faz, et al.
Journal of Neuropsychology|July 15, 2015
Subtle visuomotor difficulties in preclinical Alzheimer's diseaseMaria A Mollica, Jordi Navarra, Irune Fernández-Prieto, et al.
Pageof 12

Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
Journal of Alzheimer'S Disease : JAD|January 30, 2018
Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-β and TauAlan Tucholka, Oriol Grau-Rivera, Carles Falcon, et al.
Dementia and Geriatric Cognitive Disorders Extra|September 26, 2014
Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's DiseaseChristoffer Rosén, Carl-Henrik Andersson, Ulf Andreasson, et al.
Journal of Alzheimer'S Disease : JAD|March 1, 2014
Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impairmentMircea Balasa, Raquel Sánchez-Valle, Anna Antonell, et al.
Journal of Alzheimer'S Disease : JAD|September 18, 2010
Greater default-mode network abnormalities compared to high order visual processing systems in amnestic mild cognitive impairment: an integrated multi-modal MRI studyRoser Sala-Llonch, Beatriz Bosch, Eider M Arenaza-Urquijo, et al.
Journal of Alzheimer'S Disease : JAD|October 8, 2015
Informants' Perception of Subjective Cognitive Decline Helps to Discriminate Preclinical Alzheimer's Disease from Normal AgingNatalia Valech, María A Mollica, Jaume Olives, et al.
The Journal of ECT|April 26, 2012
Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot studyLuis Pérez Pintor, Francesc Valldeoriola, Emilio Fernández-Egea, et al.
Frontiers in Psychiatry|February 23, 2026
Evaluating contributions of neuropsychological, psychiatric, and inflammatory processes to the expression of cognitive symptoms in post-acute COVID-19 syndromeLuke S Watson, Youssef Toubouti, Sarah M Gray, et al.
Revista De Neurologia|April 26, 2012
[A new approach to the Alzheimer's disease diagnosis with biomarkers: description of the AD-CSF-Index]José L Molinuevo, Juan D Gispert, Jesús Pujol, et al.
Psychiatry Research|May 7, 2011
Association between cerebrospinal fluid tau and brain atrophy is not related to clinical severity in the Alzheimer's disease continuumCristina Solé-Padullés, Albert Lladó, David Bartrés-Faz, et al.
Journal of Neuropsychology|July 15, 2015
Subtle visuomotor difficulties in preclinical Alzheimer's diseaseMaria A Mollica, Jordi Navarra, Irune Fernández-Prieto, et al.
Pageof 12